Loading BSD 13F portfolios...
Elite Manager Tracking
The Top 150 BSDs
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.
Real-time 13F holding analysis for the industry's most influential institutional investors. Track conviction shifts, new entries, and structural exits.
Institutional Investor • Venbio Partners
Value
$206M
Stocks
6 Stocks
Turnover
0.0%
Top Holdings
PHVS(42.79%) ALMS(33.96%) ACHV(10.29%) ALXO(7.11%) HRMY(4.58%)
Investment philosophy details pending verification.
| Ticker | P/C | Company Name | Sector | Market Value | Shares | Weight | Chg Shares | % Chg |
|---|---|---|---|---|---|---|---|---|
| PHVS | None | PHARVARIS N V | General | $160.6M | 0 | 42.8% | 0 | No Change |
| ALMS | None | ALUMIS INC | General | $127.4M | 0 | 34.0% | 0 | No Change |
| ACHV | None | Achieve Life Sciences, Inc | General | $38.6M | 0 | 10.3% | 0 | No Change |
| ALXO | None | Alx Oncology Holdings Inc - US | General | $26.7M | 0 | 7.1% | 0 | No Change |
| HRMY | None | Harmony Biosciences Holdings Inc - US | General | $17.2M | 0 | 4.6% | 0 | No Change |
| LYEL | None | Lyell Immunopharma Inc | General | $4.7M | 0 | 1.3% | 0 | No Change |
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| No recent buys. | ||||
| Ticker | Amount | % Chg | Weight | Status |
|---|---|---|---|---|
| No recent sells. | ||||
| Sector | Stocks | Value | Exposure |
|---|---|---|---|
| General | 6 | $375.2M | 100.0% |